TP53 and neoplasm: With respect to well‐established driver genes, TP53 and APC—two of the most frequently mutated tumor suppressors in CRC—exhibited consistently high mutation frequencies in both cohorts, highlighting their conserved roles in CRC pathogenesis regardless of ethnicity.